West Pharmaceutical Services, Inc (NYSE: WST) is 2.85% higher on its value in year-to-date trading and has touched a low of $265.00 and a high of $413.70 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The WST stock was last observed hovering at around $332.53 in the last trading session, with the day’s gains setting it 4.38%.
Currently trading at $336.91, the stock is 2.11% and 3.92% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.39 million and changing 1.32% at the moment leaves the stock 3.29% off its SMA200. WST registered -4.25% loss for a year compared to 6-month gain of 4.84%. The firm has a 50-day simple moving average (SMA 50) of $324.1904 and a 200-day simple moving average (SMA200) of $326.1894.
The stock witnessed a 4.47% loss in the last 1 month and extending the period to 3 months gives it a 17.60%, and is 2.85% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.90% over the week and 2.37% over the month.
West Pharmaceutical Services, Inc (WST) has around 10600 employees, a market worth around $24.40B and $2.88B in sales. Current P/E ratio is 49.98 and Fwd P/E is 45.10. Profit margin for the company is 17.37%. Distance from 52-week low is 27.14% and -18.56% from its 52-week high. The company has generated returns on investments over the last 12 months (16.44%).
The EPS is expected to shrink by -17.65% this year
1075.0 institutions hold shares in West Pharmaceutical Services, Inc (WST), with institutional investors hold 97.21% of the company’s shares. The shares outstanding are 72.50M, and float is at 71.99M with Short Float at 1.61%. Institutions hold 96.64% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 8.94 million shares valued at $2.95 billion. The investor’s holdings represent 12.1685 of the WST Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 7.58 million shares valued at $2.5 billion to account for 10.3118 of the shares outstanding. The other top investors are BANK OF NEW YORK MELLON CORP which holds 3.27 million shares representing 4.4543 and valued at over $1.08 billion, while STATE STREET CORP holds 4.3597 of the shares totaling 3.2 million with a market value of $1.06 billion.
West Pharmaceutical Services, Inc (WST) Insider Activity
The most recent transaction is an insider sale by Witherspoon Charles, the company’s VP & Treasurer. SEC filings show that Witherspoon Charles sold 703 shares of the company’s common stock on Oct 29 ’24 at a price of $310.40 per share for a total of $0.22 million. Following the sale, the insider now owns 1253.0 shares.
West Pharmaceutical Services, Inc disclosed in a document filed with the SEC on Aug 19 ’24 that Witherspoon Charles (VP & Treasurer) sold a total of 1,029 shares of the company’s common stock. The trade occurred on Aug 19 ’24 and was made at $300.00 per share for $0.31 million. Following the transaction, the insider now directly holds 1478.0 shares of the WST stock.
Still, SEC filings show that on May 10 ’24, Hofmann Thomas W (Director) disposed off 617 shares at an average price of $365.92 for $0.23 million. The insider now directly holds 43,565 shares of West Pharmaceutical Services, Inc (WST).
